Surgery videos shown at the 2008 Cataract Spotlight Symposium in Atlanta gave audience members a chance to ponder how they would manage similar situations. See what they said and review expert commentary.
This past November, the seventh annual Spotlight on Cataract Surgery session at the Academy’s Joint Meeting was entitled Cataract Complications—Video Case Studies: Why? What Now? How? Cochaired by Mark Packer, MD, and me, this four-hour event was organized to feature eight video cases that demonstrated a variety of cataract surgical complications.
Dr. Packer and I selected and presented the video cases, which we would pause at the point of a complication. The attendees were then asked to make clinical decisions using electronic keypads. This was followed by several rapid-fire didactic presentations on topics of relevance to the case. Next, two panel discussants (who had never viewed the case) were asked to make their own management recommendation before the video of the outcome was shown. Following additional audience polling about preferences and practices, the two panelists had the final say.
In all, more than 40 presenters and panelists spoke about managing unhappy multifocal IOL patients, intraoperative floppy iris syndrome (IFIS), vitreous loss and dropped nuclei, the Argentinean flag sign, capsulorhexis tears and zonular dialysis. Richard Lindstrom, MD, concluded the symposium by delivering the Academy’s fourth annual Charles Kelman Lecture, entitled Cataract Surgery in the Glaucoma Patient.
This article reports the results of the 32 audience response questions, along with commentary that the symposium speakers and panelists contributed after the Joint Meeting. Because of the anonymous nature of this polling method, the audience opinions are always interesting, made more so by discussion in real time during the event by the panelists.
The Academy’s Annual Meeting now features a daylong, continuous series of cataract events that constitute Cataract Monday. The Spotlight on Cataract Surgery program was followed by the ASCRS-cosponsored symposium on the Surgical Correction of Presbyopia, the Spotlight on IFIS symposium, and the Around the World in 80 Minutes International symposium on Devices for Complicated Cataract Cases—What Are American Surgeons Missing?
—DAVID F. CHANG, MD
Cataract Spotlight Program Cochairman
Chairman, Academy Annual Meeting Program Committee
Unhappy Multifocal IOL Patient
Q1: How would you manage –2.0 D surprise in a multi-focal IOL patient?
|PRK || |
|LASIK || |
|Mini-RK || |
|Piggyback IOL || |
|IOL exchange || |
|Refer to refractive surgeon || |
David Hardten This question initiates thoughts on a not-uncommon question in patients having multifocal or typical aspheric IOL implantation with cataract and lens implant surgery. It is important to have thought through management options before surgery, and I think it is helpful, in a general sense, to discuss with patients ahead of time that if they don’t achieve their goal with the refractive portion of the cataract surgery, there are options for fine-tuning refractive results postoperatively.
The spread of answers to this question shows that no one answer always solves the problem and that there are many viable options. I also tend to lean in low myopic or astigmatic errors toward laser vision correction—LASIK because of the quicker recovery in patients with normal epithelium and corneas; PRK for patients with anterior basement membrane dystrophy or other corneal abnormalities, or if I have done prior relaxing incisions. I think that many surgeons who don’t do many laser vision cases are also more comfortable with PRK than LASIK.
Piggyback IOLs are a viable option for spherical refractive errors, but they are not as good if astigmatism is involved, and it is important to verify that there is normal peripheral zonular support as well as enough depth to the space between the iris and current IOL. IOL exchange is also a viable option, albeit one that is a little more involved than other options.
Certainly if the surgeon does not do laser vision correction, then referral to someone who is familiar with these techniques is a good option. However, I think the trend over the next several years will be toward familiarity with all options for those surgeons who do a significant number of cataract procedures in patients with high expectations.
Q2: How would you manage +2.0 D surprise in a multifocal IOL patient?
|PRK || |
|LASIK || |
|CK || |
|Piggyback IOL || |
|IOL exchange || |
|Refer to refractive surgeon || |
Warren Hill It was interesting that the audience response poll showed that the majority of surgeons favored an IOL exchange and only a small percentage would select the less-challenging option of a piggyback IOL. Early in the postoperative course, and when there is no question as to the power of the IOL implanted, exchanging the correct IOL for the incorrect IOL is generally the better idea. LASIK and PRK—33 percent of the audience poll—are still reasonable alternatives, especially if there is residual refractive astigmatism.
It is encouraging that more surgeons are now willing to do an IOL exchange than may have been inclined to do this previously. With the majority of surgeons now using optical coherence biometry and immersion biometry for the measurement of axial length, and an ever-increasing number moving toward the use of newer-generation IOL power calculation formulas, such as Haigis and Holladay 2, an IOL power surprise should become a less-frequent issue.
Jack Holladay For the hyperopic surprise, IOL exchange received 43 percent, followed by LASIK at 21 percent and PRK at 12 percent. It’s interesting to compare these results with those seen with the previous question on myopic surprise. The differences are not surprising, given that most surgeons feel that the larger hyperopic laser treatments are not quite as good as their myopic counterparts, and that not re-entering the eye is a primary consideration with PRK or LASIK.
The piggyback IOL, which is an excellent alternative, received a smaller amount of support. For either myopic or hyperopic surprise, the refractive formula for calculating the secondary piggyback IOL power is exact and eliminates another surprise if the primary IOL is mislabeled.
Many IOL models are now available, ranging from –20.0 D to +10.0 D; they are made for the sulcus and provide an excellent method of treating a refractive surprise. In addition, refractive and wavefront measurements through multifocal IOLs are more difficult than through monofocal IOLs and may lead to erroneous measurements.
Q3: Despite reassurance, and trying topical brimonidine, a multifocal IOL patient has nighttime glare in his or her emmetropic first eye, along with significant posterior capsular striae. What do you recommend next?
|Nd:YAG the posterior capsule || |
|Remove multifocal IO in the first eye || |
|Implant multifocal IOL in the second eye || |
|Implant monofocal IOL in the second eye || |
|Implant accommodative IOL in the second eye || |
Kevin Waltz The audience clearly preferred to address the problem by treating the eye with the complaint, not by treating the fellow eye. While it would be important to aggressively treat any dry eye in a case like this, it was not one of the listed options. In the case of significant striae, it is reasonable to open the posterior capsule. The patient needs to understand that the capsulotomy makes a subsequent IOL exchange more difficult.
Q4: Following a YAG capsulotomy and a complaint of persistent bothersome multifocal halos, I would:
|Strongly discourage IOL exchange because of risks || |
|Exchange IOL (fold it) || |
|Exchange IOL (cut it) || |
|Exchange IOL (large incision) || |
|Refer elsewhere for IOL exchange || |
Steve Lane While the majority of respondents answered that they would discourage IOL exchange in the face of an open capsule, there are times when patients are so unhappy that surgery must be considered despite the possible complications.
It is critical that the potential complications be discussed prior to surgery. These would include cystoid macular edema (CME), retinal detachment and corneal decompensation. The surgeon embarking on such a procedure must be prepared to perform a pars plana vitrectomy and be comfortable suturing IOLs to the iris and/or transsclerally as the bag may need to be sacrificed during removal.
Most often, however, the IOL can be safely viscodissected free from the bag and prolapsed up into the anterior chamber leaving the residual capsule intact. If vitreous presents, the pars plana vitrectomy should be performed before removing the IOL to release any traction that may be present. The IOL can then be removed using any of the techniques described according to what the surgeon is most comfortable with. IOL replacement should then be performed placing the IOL in the most stable position possible, realizing that fixation to the iris or sulcus may be required.
Q5: Describe your current use of multifocal IOLs (for presbyopic correction):
|Use exclusively multifocal IOLs || |
|Use both multifocal and accommodating, but prefer multifocal IOLs || |
|Currently use both multifocal and accommodating, but prefer accommodating IOLs || |
|Tried multifocal IOLs, but stopped or rarely use now || |
|Have never implanted multifocal IOLs || |
Eric Donnenfeld Refractive IOLs are rapidly becoming mainstream treatment for presbyopia following cataract surgery. Refractive IOLs offer a unique opportunity to improve quality of life for patients. The majority of respondents have employed multifocal or accommodating IOLs, with multifocal IOLs being preferred in this survey over accommodating lenses. However, further refinement in technology is necessary, as 44 percent of respondents have not tried either of these lenses, and 12 percent of respondents have tried multifocal IOLs and have stopped using them.
Intraoperative Floppy Iris Syndrome
Q6: Do you stop tamsulosin (Flomax) prior to cataract surgery?
|Never || |
|Occasionally (< 20%) || |
|Sometimes (<20–50%) || |
|Usually (> 50%) || |
|Routinely || |
Howard Fine We never stop tamsulosin prior to cataract surgery, and that is consistent with what over 70 percent of the attendees at the symposium indicated. There are variable responses to tamsulosin and variable degrees of IFIS. Although some who have stopped it previously still have floppy irides at surgery, others who have stopped it have relatively mild floppy irides and even some who are still on it have relatively mild floppy irides.
Our procedure involves the use of preoperative atropine, three times a day, for a week prior to surgery. If the pupil has dilated, we will then use Shugarcaine, which in our experience doesn’t dilate the pupil as much as hold it in the dilated position. We would probably use Healon 5 to expand the pupil further and then we would proceed by carefully utilizing biaxial microincision phaco. This has an inordinately advantageous characteristic of tamponading the iris because the incoming fluid from the irrigating chopper is basically above the iris. Unless you irrigate under the iris, the iris does not billow and become floppy. If, however, the pupil began to come down, we would consider making a central incision and introducing either a Malyugin or a Morcher ring, which would then allow us to continue with our biaxial phaco, since the 2.2-mm incision would be self-sealing. We have basically had excellent success in this way, and our complication rate is no higher than for those who do not use alpha1 agonists.
Q7: For a pupil dilating to 7 mm in a patient who stopped tamsulosin 18 months ago, I would initially:
|Use topical atropine only || |
|Use intracameral epinephrine or phenylephrine || |
|Use Healon 5/dispersive OVD with lower fluidic settings || |
|Insert mechanical devices (hooks, ring) || |
|Other strategy || |
|Use multiple strategies || |
|Do nothing different || |
Sam Masket The key issue in managing the cataract surgery patient with past or current exposure to tamsulosin is adequacy and maintenance of pupil dilation. Most often, a pupil that dilates well will preclude the development of IFIS, as the floppy iris typically occurs in the susceptible eye when the infusing fluid is directed to the undersurface of the iris, causing the flaccid iris to balloon forward and prolapse through the cataract incisions. A widely dilated pupil generally precludes the irrigating stream of BSS from pushing the iris forward. However, even in the presence of a wide pupil at the outset of surgery, a floppy iris may develop, particularly if the pupil tends to become miotic. For that reason, surgeons need to be prepared for IFIS in all “exposed” cases.
For the case in question, the pupil dilated adequately and the patient had discontinued tamsulosin 18 months earlier. While these facts may suggest a smooth operative course, we know that patients may exhibit IFIS despite having discontinued medication and the pupil may become miotic intraoperatively despite wide dilation at the outset.
Approximately half of the respondents to this question opted for use of multiple anti-IFIS strategies. This is logical, as one may use a stepwise approach to the potential problem and add strategies sequentially. One concept that I prefer is to initiate IFIS prophylaxis pharmacologically (atropine 1 percent topically two days prior to surgery and intracameral epinephrine or phenylephrine), employ retentive viscoagents intraoperatively, alter fluidic inflow and outflow during surgery as needed and then, if necessary, employ mechanical devices, such as iris hooks or the Malyugin ring, to fixate the pupil. These strategies are synergistic, not competitive, and add to the likelihood of a successful surgical course and outcome.
Q8: In the previous patient (Q7), surgery began without using any special IFIS measures. However, the pupil constricted and started to prolapse as soon as the phaco tip was inserted with irrigation. At this point, I would:
|Proceed with phaco (nothing different) || |
|Instill Healon 5 and lower the fluidic settings || |
|Instill DisCoVisc or a dispersive OVD, using the same or lower fluidic settings || |
|Instill intracameral epinephrine || |
|Insert iris retractors || |
|Insert Malyugin or other pupil ring || |
|Other || |
Steve Arshinoff It is interesting that in the preceding question, audience members overwhelmingly stated that they would use multiple strategies to manage IFIS. We see here that once confronted in surgery with a problematic IFIS case—one that had not been previously suspected and for which the anterior chamber was not previously prepared—the audience proposed no unified approach. Instead, all strategies, except doing nothing, got significant portions of votes.
The symposium speakers would like to compliment the audience on these responses and suggest that a major takeaway message of this symposium should be to adopt a stepladder approach to IFIS, beginning with pharmacology (cholinergic blockade and adrenergic stimulation), progressing to judicious and careful use of ophthalmic viscoelastic devices (OVDs) and, finally, adding iris hooks or the Malyugin ring if needed. The audience already seems to have gotten the message, but the choice of answers did not allow them to state that, so the next best choice was to pick “your preferred isolated next strategy,” resulting in choices across the board.
Q9: How difficult is phaco with tamsulosin (compared with non-IFIS)?
|No different || |
|More difficult, but surgical risks no higher || |
|More difficult, with slightly increased risk || |
|More difficult, with much greater risk || |
Bruce Wallace IFIS remains a significant challenge for cataract surgeons. As we can glean from the responses, there really is no magic bullet to handle these cases, so multiple strategies are needed to avoid iris contact during nuclear removal.
A preoperative discussion with patients and their family members is worth considering due to the unpredictable nature of these procedures. I have found multiple reinjections of disposable DuoVisc to help protect the iris helpful, especially when a patient appears to have an adequate pupil preoperatively but miosis develops during the procedure.
Q10: Would you take tamsulosin if you had BPH and mild cataracts?
|Yes, if recommended || |
|Yes, but have cataract surgery first || |
|No, take a nonselective alpha-blocker || |
|No, avoid all alpha-blockers if possible || |
|Too late, I’m already taking it || |
Nick Mamalis It is interesting that almost one-fourth of respondents stated that they would take tamsulosin if recommended. This likely reflects the fact that this particular group of surgeons either does not realize the risks involved with cataract surgery and IFIS or has faith that this surgery can be performed without significant increased risk. Of interest is the fact that greater than half of the respondents stated that they would either take a nonselective alpha-blocker or avoid all alpha-blockers if possible. This likely reflects the fact that the surgeons are concerned that cataract surgery in patients with tamsulosin and subsequent IFIS can be more difficult or have an increased risk of complication. Only 16 percent of respondents stated that they would have cataract surgery done prior to starting this medication. These results highlight the broad range of opinion that cataract surgeons have regarding tamsulosin in patients with mild cataracts.
Q11: During hydrodissection there is sudden pupil expansion and egress of OVD out of the side ports. At this point I would:
|Loosen the nucleus by rotating it || |
|Initiate phaco in the bag without rotation || |
|Prolapse the nucleus into the anterior chamber for phaco || |
|Convert to manual large incision ECCE || |
|Do PAL technique || |
Walter Stark A sudden pupil expansion with deepening of the anterior chamber during phaco can indicate a break in the posterior capsule or possibly extreme weakness of the zonules. A break in the posterior capsule should be suspected if the patient has had prior vitrectomy with possible damage to the posterior capsule.
I agree with the respondents that the best technique is to prolapse the nucleus into the anterior chamber for phaco. This is facilitated if the patient has a wide capsulotomy and if good hydrodissection was performed. However, more aggressive hydrodissection could further extend the posterior capsular tear and hasten dislocation of the nucleus.
The nucleus can be brought into the anterior chamber by the posterior assisted levitation (PAL) technique or by lowering the infusion bottle and using the phaco tip to burrow into the nucleus and then lift the nucleus into the anterior chamber.
These techniques can be combined. Once the nucleus is in the pupillary plane and free of its attachments to the capsule, infusion pressure can be increased slightly to avoid collapse of the anterior chamber. After removal of the nucleus—and cortex and any prolapsed vitreous—a three-piece acrylic IOL, Alcon’s 6.5 mm MA50BM, can be inserted into the posterior chamber, anterior to any remaining capsule, with pupillary capture of the optic. A single-piece acrylic IOL should not be placed in the sulcus as it may cause UGH (uveitis-glaucoma-hyphema) syndrome. The haptics can be sutured to the peripheral iris superiorly and, if necessary, inferiorly with a 10-0 Prolene suture on a CTC needle. Once securely sutured, the IOL optic is placed in the posterior chamber. Remember to decrease the power of the IOL by 0.5 D, as the lens is further forward in the eye.
Q12: The lens was rotated and began to sink posteriorly. At this point I would:
|Attempt to aspirate the nucleus with the phaco tip || |
|Levitate the nucleus with a PAL technique || |
|Abandon the nucleus—without implanting an IOL || |
|Abandon the nucleus—perform a vitrectomy and implant an IOL || |
Julia Haller The audience response here reflects an appropriately thoughtful, careful approach by the participants. Overall, 17 percent felt more comfortable delaying implantation of an IOL, while 68 percent had the experience required to go ahead and place an IOL in the sulcus. It is worth considering a “safety suture” in such cases, particularly if there are significant areas of questionable or missing capsular support. Interestingly, 14 percent of the audience has acquired enough experience with the PAL technique to employ that approach. Presumably this reflects their observation that the nucleus is still positioned anteriorly enough for this technique to be used safely. They may want to have the patient checked by a retina colleague postoperatively for any evidence of peripheral retinal issues. This case illustrates one of many situations where collegial collaboration between anterior and posterior segment surgeons can benefit patients enormously.
Q13: With a dropped nucleus and insufficient anterior or posterior capsular support, which IOL would you insert?
|No IOL—defer until after the nucleus was removed by a vitreoretinal surgeon || |
|ACIOL || |
|Scleral sutured PCIOL || |
|Iris sutured PCIOL || |
Roger Steinert Both the existing literature and the audience are in agreement. A well-sized and well-positioned modern anterior chamber IOL gives good results. The literature data suggest that skilled implantation of a sutured PCIOL results in less IOP elevation, but it has the potential to come with increased rates of IOL tilt and retinal detachment. Regarding the “no IOL” alternative, the retina specialist in another talk expressed the opinion that implantation of an IOL with a dropped nucleus is acceptable. Only an extremely dense and large nucleus might require delivery of the nuclear fragment into the anterior chamber during the secondary vitreoretinal procedure.
Q14: Are you comfortable suture fixating a PCIOL?
|Not comfortable doing this || |
|Comfortable with and prefer iris suturing || |
|Comfortable with and prefer scleral suturing || |
|Comfortable with and use both iris and scleral suturing || |
Garry Condon More than 40 percent of the respondents were comfortable with suture fixation of a PCIOL in the absence of capsule support. While there still appeared to be a preference for scleral suturing, I believe the more recently reported techniques and results with iris suturing may be shifting more surgeons in that direction. Iris suture fixation of a foldable acrylic PCIOL to the iris via a 3.5-mm incision can potentially benefit those patients who are aphakic, need IOL exchange or develop loss of capsule support during primary cataract surgery. Potential advantages over scleral fixation include less astigmatism, no suture exposure risks and less likelihood of suture breakage.
Descending Nuclear Fragments
Q15: During phaco, there is a sudden and momentary widening of the pupil, expansion of the chamber and partial posterior movement of multiple chopped nuclear fragments. What now?
|Close the eye and refer the patient || |
|Try to continue phaco || |
|Convert to large incision ECCE || |
|PAL technique followed by phaco of the fragments || |
|PAL technique followed by manual large incision extraction of the fragments || |
Rosa Braga-Mele When the capsule breaks and there are still some nuclear fragments, it is imperative that one stops phaco but does not withdraw the phaco hand. At this point the use of viscoelastic to maintain chamber stability is essential. The fact that 27 percent of the audience would continue to phaco is a bit disconcerting as this would likely push the remaining pieces into the vitreous and draw up vitreous, likely causing more problems.
The next step would depend on where the loose fragments are situated. If they are still visible in the anterior vitreous, then either floating them up anteriorly or using a PAL technique is an excellent idea. Once the fragments are supported anteriorly with either viscoelastic or a Sheets glide posteriorly, then one can proceed with phaco at lower flow parameters.
Q16: Have you used the PAL technique for descending nucleus?
|I have tried it, and it is my preference for this situation || |
|I have tried it—bad idea/not comfortable || |
|I have never tried it but would consider trying || |
|I have never and wouldn’t ever do it || |
Richard Packard Although PAL is not a new technique by any means, it was perhaps surprising that only a third of respondents had even tried it. Gratifyingly, however, the majority of those in this subset preferred using it in this difficult situation. Of those who had not tried it, almost three-quarters would consider trying what I regard as a useful bailout technique when nuclear pieces are held in the immediate area of the ruptured posterior capsule.
Q17: Have you performed an anterior vitrectomy through a pars plana sclerotomy?
|I have tried it, and it is my preference for vitreous prolapse || |
|I have tried it—bad idea/not comfortable || |
|I have never tried it but would consider trying || |
|I have never and wouldn’t ever do it || |
Jay Duker I find it interesting that nearly one-third of cataract surgeons polled currently prefer the pars plana entry site for performing anterior vitrectomy. Nevertheless, almost the same percentage of respondents does not plan on using pars plana vitrectomy in the near future. The pars plana approach to anterior vitrectomy has definitely gained a following among anterior segment surgeons, but those preferring the technique remain in the minority.
Skip Nichamin I am pleasantly surprised to see that almost one-third of respondents are currently employing a pars plana approach when faced with the need to perform an anterior vitrectomy, and that nearly 40 percent more feel that it is a good idea and will consider doing so in the future. This speaks to the fact that there is logic and benefit behind this technique, and that the corpus of practicing ophthalmologists are indeed open to new ideas and continue to be willing to learn techniques that at one time would have been considered verboten. At the heart of this discussion resides the unmitigated desire to do what is in our patient’s best interest, especially in complex settings.
Q18: Following posterior capsular rupture and anterior vitrectomy, but no retained nucleus, would you refer the patient for a retina consultation within the first few weeks?
|Yes, I would routinely refer this patient || |
|I would only refer if the patient had other risk factors (e.g., high myopia or a history of retinal detachment) || |
|I would only refer if there was retained cortex/ epinucleus || |
|I would observe and only refer if it later became necessary || |
Harry Flynn The audience response was in agreement with immediate retinal consultation, and I strongly concur with this recommendation. Eyes with displaced or retained lens fragments have a high rate of retinal detachment. Early consultation may allow detection of retinal breaks before retinal detachment occurs. Appropriate early treatment and follow-up may allow optimal visual outcomes.
A small minority of the audience, 3 percent, would refer to a retina specialist only if the patient were myopic or had a history of retinal detachment.
Approximately one-quarter of respondents would refer only if retained cortex or epinucleus were present. Eyes with substantial vitreous loss and persistent vitreo-iridal adhesions may be at risk for delayed traction and CME, even if no lens material is retained. A retinal colleague could help in the continued follow-up of such patients.
The final option was observation with no referral. If the cataract surgeon is comfortable with examining the peripheral retina and managing CME, then this option can be considered.
Elsewhere at the Joint Meeting, a series of 459 patients with retained lens fragments after cataract surgery was presented.1 All patients were managed by vitrectomy, and the retinal detachment rate was 11.8 percent. The primary causes of decreased vision in this series were retinal detachment, corneal edema and CME.
1 Olmos, L. C. et al. Poster #27, Retinal detachment rates and visual acuity outcomes of patients undergoing pars plana vitrectomy for retained lens fragments. Presented at the Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology, Saturday, Nov. 8, and Sunday, Nov. 9, 2008. View this poster at www.aao.scientificposters.com.
Mature White Lens
Q19: For a white lens, I stain the capsule with dye:
|And use an air bubble || |
|And use Healon 5 || |
|And use another OVD || |
|Via direct injection || |
Uday Devgan Using a dye such as trypan blue to stain the capsule can facilitate capsulorhexis creation in eyes with white cataracts. While these dyes are generally considered safe to use in the eye, care should be taken to protect the corneal endothelial cells and minimize the intracameral dose of dye used.
The majority of cataract surgeons use an air bubble in the anterior chamber so that only a few drops of dye are needed for capsule staining and there is minimal, if any, dye contact with the corneal endothelium. Injecting a small amount of dye under viscoelastics, particularly super-cohesives like Healon 5, is also an appropriate choice and may be more efficient.
Directly injecting a large quantity of capsular dye into the anterior chamber should be avoided in order to minimize the risks and the potential for corneal endothelial cell damage.
Q20: Argentinean flag tear1 with a white lens—at this point, I would:
|Perform a can opener capsulotomy and continue phaco in bag || |
|Prolapse the nucleus into the AC and continue phaco || |
|Convert to ECCE (temporal incision) || |
|Convert to ECCE (superior incision) || |
Bob Osher Once the Argentinean flag has occurred, the anterior capsular extension will likely arrest in the zonules. Yet it doesn’t take much force to extend the tear around the equator through the posterior capsule. Then the surgeon is in real trouble because both the anterior and the posterior are compromised.
Any of the above choices will work, although I would prefer to inject Healon 5, snip the capsule with microscissors, then perform an anterior capsulotomy trying to leave the peripheral anterior capsule intact. Following slow-motion phaco with torsional ultrasound, the cortex would be removed carefully. I would implant a single-piece IOL, orienting the lens perpendicular to the tear while the haptics were still folded over the optic, preventing contact with the equator of the bag. Once the OVD was removed, the IOL would open within the bag.
If this strategy failed, I would fall back on either sulcus or iris fixation or an anterior chamber IOL.
1 A horizontal tear across the typan blue-stained anterior capsule.